Dysgeusia is an uncommonly reported side effect associated with angiotensin-converting enzyme inhibitors (ACE inhibitors). [1] The onset is almost always within the first 3 months and is ...
Common causes of Dysgeusia include chemotherapy, asthma treatments, zinc deficiency, Liver disease, hypothyroidism, and more.
“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...